scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)

Q: What does CUSIP 810648105 represent in this 13F holders report?

CUSIP 810648105 is the security identifier for SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in Q1 2018?

37 institutional investors reported SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share for Q1 2018. Use the holders table for investor-level position and value details.

CUSIP: 810648105

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 53,364,241
Total 13F shares: 8,320,407
Share change: +513,735
Total reported value: $103,170,760
Price per share: $12.40
Number of holders: 37
Value change: +$6,465,196
Number of buys: 29
Number of sells: 12

Security key

810648105

Report period

Q1 2018

Institutions

Top holders

SCPH full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2018 Previous quarter: Q4 2017 scPharmaceuticals Inc. SEC filings scPharmaceuticals Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 810648105

Newer quarter: Q2 2018 Previous quarter: Q4 2017

Recent filing periods:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Ownership snapshot

Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

ORBIMED ADVISORS LLC

13D/G signal

—

Evidence rows

Latest as of

31 Dec 2017

13F Lead comparable stake: 6.4% Showing first 8 of 23 holder rows. Open remaining rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	6.4%	$41,225,000 3,409,865 shares	—	31 Dec 2017
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	5.4%	$34,543,000 2,857,143 shares	—	31 Dec 2017
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	0.57%	$3,684,000 304,709 shares	—	31 Dec 2017
FMR LLC	13F Company 13F	0.37%	$2,418,000 200,000 shares	—	31 Dec 2017
VANGUARD GROUP INC	13F Company 13F	0.34%	$2,177,000 180,000 shares	—	31 Dec 2017
Alyeska Investment Group, L.P.	13F Company 13F	0.33%	$2,116,000 175,000 shares	—	31 Dec 2017
AWM Investment Company, Inc.	13F Company 13F	0.31%	$1,996,000 165,100 shares	—	31 Dec 2017
Nicholas Investment Partners, LP	13F Company 13F	0.23%	$1,500,000 124,074 shares	—	31 Dec 2017

Show 15 additional holder rows in the full holder list

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Bain Capital Public Equity Management, LLC	13F Company 13F	0.2%	$1,291,000 106,794 shares	—	31 Dec 2017
DAFNA Capital Management LLC	13F Company 13F	0.18%	$1,186,000 98,100 shares	—	31 Dec 2017
GOLDMAN SACHS GROUP INC	13F Company 13F	0.1%	$653,000 54,032 shares	—	31 Dec 2017
MILLENNIUM MANAGEMENT LLC	13F Company 13F	0.07%	$462,000 38,182 shares	—	31 Dec 2017
Bank of New York Mellon Corp	13F Company 13F	0.06%	$414,000 34,269 shares	—	31 Dec 2017
TD ASSET MANAGEMENT INC	13F Company 13F	0.02%	$157,000 12,963 shares	—	31 Dec 2017
NEW YORK STATE COMMON RETIREMENT FUND	13F Company 13F	0.02%	$114,000 9,445 shares	—	31 Dec 2017
NORGES BANK	13F Company 13F	0.02%	$109,000 9,000 shares	—	31 Dec 2017
MORGAN STANLEY	13F Company 13F	0.01%	$61,000 5,065 shares	—	31 Dec 2017
BlackRock Finance, Inc.	13F Company 13F	0%	$16,000 1,364 shares	—	31 Dec 2017
UBS Group AG	13F Company 13F	0%	$13,000 1,108 shares	—	31 Dec 2017
BANK OF AMERICA CORP /DE/	13F Company 13F	0%	$7,000 617 shares	—	31 Dec 2017
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F Company 13F	0%	$4,000 357 shares	—	31 Dec 2017
Catalyst Capital Advisors LLC	13F Company 13F	0%	$4,000 350 shares	—	31 Dec 2017
WELLS FARGO & COMPANY/MN	13F Company 13F	0%	$2,000 200 shares	—	31 Dec 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

8,320,407

Rows loaded

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

Q1 2018 holders

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 value	Q1 2018 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend